BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
4.110
-1.540 (-27.26%)
Apr 7, 2026, 1:09 PM EDT - Market open

BioAtla Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
71,8011,7175,91419,61436,601
Market Cap Growth
-67.31%4.89%-70.96%-69.85%-46.41%-36.06%
Enterprise Value
8.441,7991,6685,80319,40136,360
Last Close Price
4.1128.3929.56123.00412.50981.50
PE Ratio
--0.56-0.41-0.95-3.01-7.11
PS Ratio
4.68900.72156.13--146405.61
PB Ratio
--49.78120.3983.68108.76173.61
P/TBV Ratio
-0.13-0.922.011.661.783.22
P/FCF Ratio
--37.37-23.87-56.80-216.28-579.70
P/OCF Ratio
--37.37-23.87-56.85-216.92-588.31
EV/Sales Ratio
4.22899.54151.67--145441.62
EV/EBITDA Ratio
--30.53-22.85-45.17-181.41-382.30
EV/EBIT Ratio
--30.34-22.56-44.75-179.40-377.03
EV/FCF Ratio
--37.32-23.19-55.74-213.93-575.89
Debt / Equity Ratio
-0.13-0.1300.010.010.02
Debt / EBITDA Ratio
-0.10-0.10-0.01-0.02-0.04-0.06
Debt / FCF Ratio
-0.13-0.13-0.01-0.02-0.04-0.08
Net Debt / Equity Ratio
0.030.03-3.38-1.54-1.17-1.14
Net Debt / EBITDA Ratio
0.020.020.660.851.982.52
Net Debt / FCF Ratio
0.020.020.671.052.333.80
Asset Turnover
0.060.060.13000.00
Quick Ratio
0.320.323.373.939.3212.36
Current Ratio
0.370.373.524.119.5312.48
Return on Equity (ROE)
543.76%543.76%-164.30%-98.37%-54.44%-45.34%
Return on Assets (ROA)
-179.03%-179.03%-85.94%-75.10%-45.04%-38.63%
Return on Invested Capital (ROIC)
593.91%593.91%512.41%867.07%1062.17%1310.59%
Return on Capital Employed (ROCE)
-398.18%-398.18%-114.47%-88.25%-49.47%-43.12%
Earnings Yield
-636.72%-177.91%-243.57%-104.88%-33.21%-14.06%
FCF Yield
-514.91%-2.68%-4.19%-1.76%-0.46%-0.17%
Buyback Yield / Dilution
-21.11%-21.11%-1.67%-22.74%-12.62%-207.55%
Total Shareholder Return
-21.11%-21.11%-1.67%-22.74%-12.62%-207.55%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q